Advertisement
Screener

ImmuCell Corporation (ICCC) Increase (Decrease) in Security Deposits

2.8 / 5 stars · 68/120 Roast Me

ImmuCell Corporation Increase (Decrease) in Security Deposits

ImmuCell Corporation (ICCC) reported Increase (Decrease) in Security Deposits of $287.68 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInSecurityDeposits · last filed 2017-11-13

  • ImmuCell Corporation increase (decrease) in security deposits for the quarter ending 2017-09-30 was $575.36K.
  • ImmuCell Corporation increase (decrease) in security deposits for the quarter ending 2017-06-30 was -$312.42K, a 5147.94% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in security deposits for the quarter ending 2017-03-31 was $24.74K.
  • ImmuCell Corporation increase (decrease) in security deposits for the quarter ending 2016-12-31 was -$1.32K, a 110.52% decline year-over-year.
  • ImmuCell Corporation increase (decrease) in security deposits for fiscal 2016 was -$295.81K.
  • ImmuCell Corporation increase (decrease) in security deposits for fiscal 2015 was -$13.10K.
  • ImmuCell Corporation increase (decrease) in security deposits for fiscal 2014 was -$15.28K.
Period endIncrease (Decrease) in Security Deposits 3 monthIncrease (Decrease) in Security Deposits 6 monthIncrease (Decrease) in Security Deposits 9 monthIncrease (Decrease) in Security Deposits 12 month
2017-09-30$575.36K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13
$262.94K
derived: sum of 2 quarters · filed 2017-11-13
$287.68K
10-Q · filed 2017-11-13
$286.36K
derived: sum of 4 quarters · filed 2017-11-13
2017-06-30-$312.42K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
-$287.68K
10-Q · filed 2017-08-14
-$289.00K
derived: sum of 3 quarters · filed 2017-08-14
-$573.86K
derived: sum of 4 quarters · filed 2017-08-14
2017-03-31$24.74K
10-Q · filed 2017-05-11
$23.42K
derived: sum of 2 quarters · filed 2017-05-11
-$261.44K
derived: sum of 3 quarters · filed 2017-05-11
-$255.25K
derived: sum of 4 quarters · filed 2017-05-11
2016-12-31-$1.32K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
-$286.18K
derived: sum of 2 quarters · filed 2017-03-30
-$279.99K
derived: sum of 3 quarters · filed 2017-03-30
-$295.81K
10-K · filed 2017-03-30
2016-09-30-$284.86K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
-$278.67K
derived: sum of 2 quarters · filed 2016-11-10
-$294.49K
10-Q · filed 2016-11-10
-$281.94K
derived: sum of 4 quarters · filed 2016-11-10
2016-06-30$6.19K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11
-$9.63K
10-Q · filed 2016-08-11
$2.92K
derived: sum of 3 quarters · filed 2016-08-11
-$20.93K
derived: sum of 4 quarters · filed 2016-08-11
2016-03-31-$15.82K
10-Q · filed 2016-05-11
-$3.27K
derived: sum of 2 quarters · filed 2016-05-11
-$27.12K
derived: sum of 3 quarters · filed 2016-05-11
-$28.92K
derived: sum of 4 quarters · filed 2016-05-11
2015-12-31$12.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$11.30K
derived: sum of 2 quarters · filed 2016-03-25
-$13.10K
derived: sum of 3 quarters · filed 2016-03-25
-$13.10K
10-K · filed 2016-03-25
2015-09-30-$23.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12
-$25.65K
derived: sum of 2 quarters · filed 2015-11-12
-$25.65K
10-Q · filed 2015-11-12
2015-06-30-$1.80K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
-$1.80K
10-Q · filed 2015-08-13
2015-03-31$0.00
10-Q · filed 2015-05-12
2014-12-31-$15.28K
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92